nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—BCHE—diaphragm—ovarian cancer	0.21	0.334	CbGeAlD
Cyclopentolate—CHRM3—muscle of abdomen—ovarian cancer	0.206	0.328	CbGeAlD
Cyclopentolate—BCHE—myometrium—ovarian cancer	0.0255	0.0406	CbGeAlD
Cyclopentolate—Ataxia—Altretamine—ovarian cancer	0.0251	0.0678	CcSEcCtD
Cyclopentolate—CHRM1—female reproductive system—ovarian cancer	0.0204	0.0324	CbGeAlD
Cyclopentolate—BCHE—uterine cervix—ovarian cancer	0.0199	0.0316	CbGeAlD
Cyclopentolate—CHRM3—female reproductive system—ovarian cancer	0.0182	0.029	CbGeAlD
Cyclopentolate—Hyperpyrexia—Paclitaxel—ovarian cancer	0.018	0.0485	CcSEcCtD
Cyclopentolate—BCHE—endometrium—ovarian cancer	0.018	0.0286	CbGeAlD
Cyclopentolate—CHRM3—female gonad—ovarian cancer	0.0166	0.0264	CbGeAlD
Cyclopentolate—BCHE—uterus—ovarian cancer	0.0166	0.0263	CbGeAlD
Cyclopentolate—BCHE—female reproductive system—ovarian cancer	0.0149	0.0237	CbGeAlD
Cyclopentolate—CHRM3—testis—ovarian cancer	0.0147	0.0234	CbGeAlD
Cyclopentolate—Vertigo—Altretamine—ovarian cancer	0.0145	0.039	CcSEcCtD
Cyclopentolate—BCHE—bone marrow—ovarian cancer	0.014	0.0223	CbGeAlD
Cyclopentolate—Convulsion—Altretamine—ovarian cancer	0.014	0.0376	CcSEcCtD
Cyclopentolate—BCHE—vagina—ovarian cancer	0.0135	0.0214	CbGeAlD
Cyclopentolate—BCHE—testis—ovarian cancer	0.012	0.0191	CbGeAlD
Cyclopentolate—Vasodilation—Vinorelbine—ovarian cancer	0.0113	0.0306	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Vinorelbine—ovarian cancer	0.0113	0.0306	CcSEcCtD
Cyclopentolate—Lacrimation—Docetaxel—ovarian cancer	0.00967	0.0261	CcSEcCtD
Cyclopentolate—Ataxia—Chlorambucil—ovarian cancer	0.00894	0.0241	CcSEcCtD
Cyclopentolate—BCHE—lymph node—ovarian cancer	0.00871	0.0138	CbGeAlD
Cyclopentolate—Lacrimation increased—Paclitaxel—ovarian cancer	0.00728	0.0196	CcSEcCtD
Cyclopentolate—Hallucination—Chlorambucil—ovarian cancer	0.00654	0.0176	CcSEcCtD
Cyclopentolate—Lacrimation—Epirubicin—ovarian cancer	0.00652	0.0176	CcSEcCtD
Cyclopentolate—Lacrimation increased—Docetaxel—ovarian cancer	0.00617	0.0166	CcSEcCtD
Cyclopentolate—Lacrimation—Doxorubicin—ovarian cancer	0.00603	0.0163	CcSEcCtD
Cyclopentolate—Paralysis—Epirubicin—ovarian cancer	0.00552	0.0149	CcSEcCtD
Cyclopentolate—Tremor—Chlorambucil—ovarian cancer	0.00536	0.0145	CcSEcCtD
Cyclopentolate—Flushing—Melphalan—ovarian cancer	0.00532	0.0143	CcSEcCtD
Cyclopentolate—Agitation—Chlorambucil—ovarian cancer	0.00526	0.0142	CcSEcCtD
Cyclopentolate—Paralysis—Doxorubicin—ovarian cancer	0.00511	0.0138	CcSEcCtD
Cyclopentolate—Convulsion—Chlorambucil—ovarian cancer	0.00496	0.0134	CcSEcCtD
Cyclopentolate—Flushing—Vinorelbine—ovarian cancer	0.00465	0.0125	CcSEcCtD
Cyclopentolate—Ataxia—Paclitaxel—ovarian cancer	0.00458	0.0123	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Epirubicin—ovarian cancer	0.00436	0.0118	CcSEcCtD
Cyclopentolate—Vasodilation—Epirubicin—ovarian cancer	0.00436	0.0118	CcSEcCtD
Cyclopentolate—Convulsion—Melphalan—ovarian cancer	0.00432	0.0117	CcSEcCtD
Cyclopentolate—Abdominal distension—Paclitaxel—ovarian cancer	0.00424	0.0114	CcSEcCtD
Cyclopentolate—Lacrimation increased—Epirubicin—ovarian cancer	0.00416	0.0112	CcSEcCtD
Cyclopentolate—Vasodilation—Doxorubicin—ovarian cancer	0.00404	0.0109	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Doxorubicin—ovarian cancer	0.00404	0.0109	CcSEcCtD
Cyclopentolate—Tachycardia—Melphalan—ovarian cancer	0.00397	0.0107	CcSEcCtD
Cyclopentolate—Vertigo—Vinorelbine—ovarian cancer	0.00392	0.0106	CcSEcCtD
Cyclopentolate—Coordination abnormal—Epirubicin—ovarian cancer	0.0039	0.0105	CcSEcCtD
Cyclopentolate—Ataxia—Docetaxel—ovarian cancer	0.00388	0.0105	CcSEcCtD
Cyclopentolate—Lacrimation increased—Doxorubicin—ovarian cancer	0.00385	0.0104	CcSEcCtD
Cyclopentolate—Conjunctivitis—Paclitaxel—ovarian cancer	0.00365	0.00983	CcSEcCtD
Cyclopentolate—Coordination abnormal—Doxorubicin—ovarian cancer	0.00361	0.00974	CcSEcCtD
Cyclopentolate—Coma—Epirubicin—ovarian cancer	0.0035	0.00945	CcSEcCtD
Cyclopentolate—Tachycardia—Vinorelbine—ovarian cancer	0.00347	0.00936	CcSEcCtD
Cyclopentolate—Pruritus—Chlorambucil—ovarian cancer	0.00331	0.00891	CcSEcCtD
Cyclopentolate—Coma—Doxorubicin—ovarian cancer	0.00324	0.00874	CcSEcCtD
Cyclopentolate—Flushing—Paclitaxel—ovarian cancer	0.00313	0.00843	CcSEcCtD
Cyclopentolate—Conjunctivitis—Docetaxel—ovarian cancer	0.00309	0.00834	CcSEcCtD
Cyclopentolate—Pruritus—Topotecan—ovarian cancer	0.00294	0.00793	CcSEcCtD
Cyclopentolate—Pruritus—Melphalan—ovarian cancer	0.00288	0.00777	CcSEcCtD
Cyclopentolate—Vision blurred—Paclitaxel—ovarian cancer	0.00276	0.00745	CcSEcCtD
Cyclopentolate—Tremor—Paclitaxel—ovarian cancer	0.00275	0.00741	CcSEcCtD
Cyclopentolate—Agitation—Paclitaxel—ovarian cancer	0.00269	0.00727	CcSEcCtD
Cyclopentolate—Flushing—Docetaxel—ovarian cancer	0.00265	0.00714	CcSEcCtD
Cyclopentolate—Vertigo—Paclitaxel—ovarian cancer	0.00263	0.0071	CcSEcCtD
Cyclopentolate—Rash—Topotecan—ovarian cancer	0.00262	0.00707	CcSEcCtD
Cyclopentolate—Dermatitis—Topotecan—ovarian cancer	0.00262	0.00706	CcSEcCtD
Cyclopentolate—Ataxia—Epirubicin—ovarian cancer	0.00262	0.00706	CcSEcCtD
Cyclopentolate—Rash—Melphalan—ovarian cancer	0.00257	0.00692	CcSEcCtD
Cyclopentolate—Dermatitis—Melphalan—ovarian cancer	0.00257	0.00692	CcSEcCtD
Cyclopentolate—Convulsion—Paclitaxel—ovarian cancer	0.00254	0.00685	CcSEcCtD
Cyclopentolate—Pruritus—Vinorelbine—ovarian cancer	0.00252	0.00679	CcSEcCtD
Cyclopentolate—Dry mouth—Paclitaxel—ovarian cancer	0.00244	0.00658	CcSEcCtD
Cyclopentolate—Abdominal distension—Epirubicin—ovarian cancer	0.00242	0.00653	CcSEcCtD
Cyclopentolate—Ataxia—Doxorubicin—ovarian cancer	0.00242	0.00653	CcSEcCtD
Cyclopentolate—Tachycardia—Paclitaxel—ovarian cancer	0.00234	0.0063	CcSEcCtD
Cyclopentolate—Rash—Vinorelbine—ovarian cancer	0.00224	0.00605	CcSEcCtD
Cyclopentolate—Dermatitis—Vinorelbine—ovarian cancer	0.00224	0.00604	CcSEcCtD
Cyclopentolate—Abdominal distension—Doxorubicin—ovarian cancer	0.00224	0.00604	CcSEcCtD
Cyclopentolate—Convulsion—Docetaxel—ovarian cancer	0.00215	0.00581	CcSEcCtD
Cyclopentolate—Drowsiness—Epirubicin—ovarian cancer	0.00215	0.00578	CcSEcCtD
Cyclopentolate—Somnolence—Paclitaxel—ovarian cancer	0.00213	0.00574	CcSEcCtD
Cyclopentolate—Conjunctivitis—Epirubicin—ovarian cancer	0.00209	0.00562	CcSEcCtD
Cyclopentolate—Dry mouth—Docetaxel—ovarian cancer	0.00207	0.00558	CcSEcCtD
Cyclopentolate—Drowsiness—Doxorubicin—ovarian cancer	0.00198	0.00535	CcSEcCtD
Cyclopentolate—Tachycardia—Docetaxel—ovarian cancer	0.00198	0.00534	CcSEcCtD
Cyclopentolate—Conjunctivitis—Doxorubicin—ovarian cancer	0.00193	0.0052	CcSEcCtD
Cyclopentolate—Somnolence—Docetaxel—ovarian cancer	0.0018	0.00486	CcSEcCtD
Cyclopentolate—Flushing—Epirubicin—ovarian cancer	0.00179	0.00482	CcSEcCtD
Cyclopentolate—Pruritus—Paclitaxel—ovarian cancer	0.00169	0.00456	CcSEcCtD
Cyclopentolate—Flushing—Doxorubicin—ovarian cancer	0.00165	0.00446	CcSEcCtD
Cyclopentolate—Vision blurred—Epirubicin—ovarian cancer	0.00158	0.00426	CcSEcCtD
Cyclopentolate—Agitation—Epirubicin—ovarian cancer	0.00154	0.00415	CcSEcCtD
Cyclopentolate—Rash—Paclitaxel—ovarian cancer	0.00151	0.00407	CcSEcCtD
Cyclopentolate—Dermatitis—Paclitaxel—ovarian cancer	0.00151	0.00406	CcSEcCtD
Cyclopentolate—Vertigo—Epirubicin—ovarian cancer	0.00151	0.00406	CcSEcCtD
Cyclopentolate—Vision blurred—Doxorubicin—ovarian cancer	0.00146	0.00394	CcSEcCtD
Cyclopentolate—Convulsion—Epirubicin—ovarian cancer	0.00145	0.00392	CcSEcCtD
Cyclopentolate—Pruritus—Docetaxel—ovarian cancer	0.00144	0.00387	CcSEcCtD
Cyclopentolate—Agitation—Doxorubicin—ovarian cancer	0.00143	0.00384	CcSEcCtD
Cyclopentolate—Dry mouth—Epirubicin—ovarian cancer	0.0014	0.00376	CcSEcCtD
Cyclopentolate—Vertigo—Doxorubicin—ovarian cancer	0.00139	0.00376	CcSEcCtD
Cyclopentolate—Convulsion—Doxorubicin—ovarian cancer	0.00134	0.00362	CcSEcCtD
Cyclopentolate—Tachycardia—Epirubicin—ovarian cancer	0.00134	0.0036	CcSEcCtD
Cyclopentolate—Dry mouth—Doxorubicin—ovarian cancer	0.00129	0.00348	CcSEcCtD
Cyclopentolate—Rash—Docetaxel—ovarian cancer	0.00128	0.00345	CcSEcCtD
Cyclopentolate—Dermatitis—Docetaxel—ovarian cancer	0.00128	0.00345	CcSEcCtD
Cyclopentolate—Tachycardia—Doxorubicin—ovarian cancer	0.00124	0.00333	CcSEcCtD
Cyclopentolate—Somnolence—Epirubicin—ovarian cancer	0.00122	0.00328	CcSEcCtD
Cyclopentolate—Somnolence—Doxorubicin—ovarian cancer	0.00113	0.00303	CcSEcCtD
Cyclopentolate—Pruritus—Epirubicin—ovarian cancer	0.000968	0.00261	CcSEcCtD
Cyclopentolate—Pruritus—Doxorubicin—ovarian cancer	0.000896	0.00241	CcSEcCtD
Cyclopentolate—Rash—Epirubicin—ovarian cancer	0.000863	0.00233	CcSEcCtD
Cyclopentolate—Dermatitis—Epirubicin—ovarian cancer	0.000862	0.00232	CcSEcCtD
Cyclopentolate—Rash—Doxorubicin—ovarian cancer	0.000798	0.00215	CcSEcCtD
Cyclopentolate—Dermatitis—Doxorubicin—ovarian cancer	0.000797	0.00215	CcSEcCtD
